NovoCure Limited (NVCR) is in Healthcare, Medical Devices, based in Switzerland, listed on NasdaqGS. Market cap 1.66B USD. 52-week range 9.82 to 21.45 USD. Data as of 2026-10-09.
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, ...